These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
305 related items for PubMed ID: 31965112
1. Practical approach to diagnosis of bland-looking spindle cell lesions of the breast. Magro G, Salvatorelli L, Puzzo L, Piombino E, Bartoloni G, Broggi G, Vecchio GM. Pathologica; 2019 Dec; 111(4):344-360. PubMed ID: 31965112 [Abstract] [Full Text] [Related]
4. Dermatofibrosarcoma protuberans: a tumor in the wide spectrum of the bland-looking spindle cell lesions of the breast. Vecchio GM, Broggi G, Mulè A, Piombino E, Magro G. Pathologica; 2019 Sep; 111(3):87-91. PubMed ID: 31748754 [Abstract] [Full Text] [Related]
8. Lipomatous myofibroblastoma: a potential diagnostic pitfall in the spectrum of the spindle cell lesions of the breast. Magro G, Michal M, Vasquez E, Bisceglia M. Virchows Arch; 2000 Nov; 437(5):540-4. PubMed ID: 11147176 [Abstract] [Full Text] [Related]
9. Myofibroblastic, fibroblastic and myoid lesions of the breast. Krings G, McIntire P, Shin SJ. Semin Diagn Pathol; 2017 Sep; 34(5):427-437. PubMed ID: 28751104 [Abstract] [Full Text] [Related]
10. Benign spindle cell tumor of the breast with prominent adipocytic component. Magro G, Bisceglia M, Pasquinelli G. Ann Diagn Pathol; 1998 Oct; 2(5):306-11. PubMed ID: 9845754 [Abstract] [Full Text] [Related]
13. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue. Perez-Montiel MD, Plaza JA, Dominguez-Malagon H, Suster S. Am J Dermatopathol; 2006 Apr; 28(2):105-11. PubMed ID: 16625070 [Abstract] [Full Text] [Related]
15. Mammary myofibroblastoma: an update with emphasis on the most diagnostically challenging variants. Magro G. Histol Histopathol; 2016 Jan; 31(1):1-23. PubMed ID: 26328916 [Abstract] [Full Text] [Related]
17. Benign spindle cell tumors of the mammary stroma: diagnostic criteria, classification, and histogenesis. Magro G, Michal M, Bisceglia M. Pathol Res Pract; 2001 Jan; 197(7):453-66. PubMed ID: 11482575 [Abstract] [Full Text] [Related]
18. An update on selected cutaneous (myo) fibroblastic mesenchymal tumors. Georgantzoglou N, Linos K. Semin Diagn Pathol; 2023 Jul; 40(4):295-305. PubMed ID: 37150655 [Abstract] [Full Text] [Related]
19. Benign Fibromyxoid Lesion of the Breast: A Distinct Entity From Benign Spindle Cell Tumors of the Mammary Stroma? Schwartz CJ, Schandl CA, Morse J, Ralston J, Rapkiewicz A, Darvishian F. Int J Surg Pathol; 2018 Sep; 26(6):488-493. PubMed ID: 29552929 [Abstract] [Full Text] [Related]
20. The significance of enhancer of zeste homolog 2 (EZH2) expression in spindle cell lesions of the breast. Genco IS, Hackman K, Morrar D, Jin C, Santagada E, Hajiyeva S. Pathol Int; 2021 Jun; 71(6):415-419. PubMed ID: 33730427 [Abstract] [Full Text] [Related] Page: [Next] [New Search]